Nu-Med Plus (NUMD) Return on Invested Capital (2016 - 2019)
Nu-Med Plus' (NUMD) quarterly Return on Invested Capital came in at 0.04% in Q3 2019, down 34.08% quarter-over-quarter from 0.06% in Q2 2019.
Nu-Med Plus (NUMD) Return on Invested Capital (2016 - 2019) Analysis & Trends
Nu-Med Plus has disclosed Return on Invested Capital across 4 years of filings, most recently posting 0.04% for Q3 2019.
- Return on Invested Capital for Q3 2019 came in at 0.04%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2019 was 0.04% (changed N/A YoY), and the FY2018 annual result was 0.17%, changed N/A from the prior year.
- Return on Invested Capital came in at 0.04% for Q3 2019 at Nu-Med Plus, down from 0.06% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.18% in Q1 2019 to a low of 0.37% in Q3 2017.
- The 4-year median for Return on Invested Capital is 0.0% (2016), against an average of 0.02%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.00% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 0.00% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 0.00% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 0.00% |
| 10 | Nu-Med Plus | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 0.04% |
| Jun 30, 2019 | 0.06% |
| Mar 31, 2019 | 0.18% |
| Dec 31, 2018 | -0.09% |
| Sep 30, 2017 | -0.37% |
| Jun 30, 2017 | -0.01% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |